Evidence map›Paper›PMID 17709203›Full record

ArticleNeuroscience letters2007

Beta-amyloid toxicity and reversal in embryonic rat septal neurons.

Karen Jarvis, Poincyane Assis-Nascimento, Laura M Mudd, Jeremy R Montague

Open access · greenAbstract read
In one paragraph

Article in Neuroscience letters, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Karen JarvisSchool of Natural and Health Sciences, SNHS-Biology 305, Barry University, 11300 NE 2nd Avenue, Miami Shores, FL 33161, USA.
Poincyane Assis-Nascimento
Laura M Mudd
Jeremy R Montague
Barry University · US

Funding

TRANSVECTION AND SILENCING IN BIOTHORAX COMPLEX OF DROSOPHILA MELANOGASTERS06GM045455 · NIGMS · BARRY UNIVERSITY · PI FREI, JOHN KAREN · 1991 to 2006
$4.1M
BIOMEDICAL RESEARCH AT BARRY UNIVERSITYR25GM059244 · NIGMS · BARRY UNIVERSITY · PI REDWAY, FLONA ARUNDEL · 2001 to 2017
$4.0M
NIGMS NIH HHS R25 GM059244NIGMS NIH HHS R25 GM 9244NIGMS NIH HHS S06 GM045455NIGMS NIH HHS S06 GM45455NIGMS NIH HHS T34GM08082
6 · The paper itself

Abstract

Alzheimer's disease is characterized mainly by loss of neurons from the septal nucleus. In this study, neurons from the septal nucleus of the embryonic day 16 (E16) rat were grown in culture with a plane of astrocytes from the embryonic rat and in a defined medium in the absence of serum. Neurons were treated with beta-amyloid (Abeta: 0.1, 1 and 10 microM) on day in vitro (DIV) 1 and DIV 4 and fluorescent microscopy was used to measure survival and apoptosis following exposure of the treated cells on DIV 7. Reversal of neurotoxicity was studied using the potentially neuroprotective agents nerve growth factor (NGF, 100 ng/ml), basic fibroblast growth factor (bFGF, 5 ng/ml), insulin-like growth factors (IGF1 and IGF2, 10 ng/ml) and estrogen (10 nM), administered on DIV 4 and DIV 5, that is, subsequent to the Abeta (10 microM)-induced neurotoxicity. Abeta caused a significant decrease in survival at 10 microM, and a significant increase in apoptosis at 0.1 and 10 microM. IGF1, IGF2 and bFGF all caused a reversal of the Abeta-induced neurotoxic effect on survival while NGF and estrogen did not under these experimental conditions.

Indexed as

Amyloid beta-PeptidesAnimalsApoptosisCells, CulturedCell SurvivalDrug Administration ScheduleEmbryo, MammalianFibroblast Growth Factor 2Insulin-Like Growth Factor IInsulin-Like Growth Factor IIMicroscopy, FluorescenceNeuronsNeuroprotective AgentsNeurotoxinsRatsRats, Sprague-DawleyAmyloid beta-PeptidesFibroblast Growth Factor 2Insulin-Like Growth Factor IInsulin-Like Growth Factor IINeuroprotective AgentsNeurotoxins

Identifiers

PMID17709203
PMCPMC2751578
OpenAlexW1966285102

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.